MediciNova MNOV
$ 1.95
-0.1%
Quarterly report 2024-Q3
added 11-13-2024
MediciNova Financial Ratios 2011-2024 | MNOV
Annual Financial Ratios MediciNova
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-7.7 | -8.2 | -11.5 | -18.6 | -19.8 | -24.0 | -26.2 | -16.8 | -12.1 | -9.9 | -12.0 | -2.9 | -1.5 |
P/S |
65.7 | - | 28.8 | - | - | - | - | - | - | - | 8.1 | 39.6 | - |
EPS |
-0.2 | -0.3 | -0.2 | -0.3 | -0.3 | -0.4 | -0.3 | -0.3 | -0.3 | -0.4 | -0.2 | -0.7 | -1.2 |
EV (Enterprise Value) |
18.6 M | 101 M | 48.4 M | 202 M | 196 M | 293 M | 269 M | 164 M | 90.2 M | 84.6 M | 45.9 M | 32.4 M | 19.6 M |
EBITDA per Share |
-0.2 | -0.3 | -0.21 | -0.317 | -0.325 | -0.378 | -0.37 | -0.329 | -0.331 | -0.382 | -0.189 | -0.63 | -1.08 |
EV/EBITDA |
-2.9 | -16.3 | -13.7 | -18.6 | -20.3 | -14.6 | -9.7 | -8.6 | -10.6 | -2.6 | -0.8 | ||
PEG |
0.94 | 7.97 | 1.6 | 2.66 | -1.19 | 1.92 | -8.64 | 42.79 | -0.92 | 0.1 | -0.17 | -0.06 | -0.06 |
P/B |
1.1 | 1.6 | 1.4 | 3.6 | 3.4 | 4.8 | 7.6 | 5.3 | 3.3 | 4.1 | 1.9 | 2.1 | 1.2 |
P/CF |
-8.8 | -9.0 | -12.4 | -23.7 | -28.0 | -38.5 | -42.2 | -27.5 | -15.0 | 111.9 | -4.5 | -2.7 | -2.1 |
ROE % |
-13.74 | -20.03 | -12.11 | -19.42 | -17.28 | -20.07 | -28.89 | -31.47 | -27.01 | -41.78 | -15.84 | -73.66 | -75.47 |
ROA % |
-12.93 | -18.97 | -11.59 | -18.37 | -16.34 | -19.00 | -25.71 | -27.29 | -23.33 | -33.72 | -13.63 | -56.02 | -57.60 |
ROCE % |
-15.87 | -20.83 | -12.21 | -19.36 | -18.23 | -20.77 | -32.14 | -28.50 | -24.23 | -35.92 | -13.82 | -59.07 | -59.46 |
Current Ratio |
17.0 | 19.0 | 23.4 | 27.7 | 28.9 | 28.6 | 9.8 | 15.2 | 15.2 | 7.6 | 31.2 | 4.3 | 4.2 |
DSO |
- | - | - | - | - | - | - | - | - | - | 365.3 | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios MediciNova
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.06 | -0.05 | -0.06 | - | -0.01 | -0.06 | -0.06 | - | -0.07 | -0.08 | -0.07 | - | -0.07 | -0.09 | - | - | -0.08 | -0.1 | -0.06 | - | -0.05 | -0.09 | -0.11 | - | -0.16 | -0.08 | -0.12 | -0.02 | -0.11 | -0.08 | -0.09 | -0.04 | -0.08 | -0.1 | -0.11 | -0.09 | -0.06 | -0.09 | -0.09 | -0.1 | -0.1 | -0.09 | -0.1 | 0.15 | -0.1 | -0.14 | -0.14 | -0.14 | -0.14 | -0.14 | -0.24 | -0.22 | -0.25 | -0.31 | -0.45 |
EBITDA per Share |
- | - | -0.06 | - | - | - | -0.06 | - | -0.08 | -0.08 | -0.07 | - | -0.07 | -0.09 | - | - | -0.08 | -0.1 | -0.07 | - | -0.06 | -0.1 | -0.12 | - | -0.17 | -0.08 | -0.12 | - | -0.11 | -0.08 | -0.09 | - | -0.08 | -0.1 | -0.11 | - | -0.06 | -0.09 | -0.09 | - | -0.1 | -0.09 | -0.1 | - | -0.1 | -0.13 | -0.13 | - | -0.14 | -0.14 | -0.24 | - | -0.25 | -0.24 | -0.31 |
ROE % |
-15.48 | -11.42 | -11.25 | -9.83 | -14.83 | -18.71 | -19.56 | -14.47 | -18.61 | -17.75 | -17.29 | -9.14 | -14.34 | -15.39 | -16.83 | -15.24 | -18.41 | -16.40 | -15.34 | -14.63 | -14.92 | -21.01 | -20.13 | -20.07 | -23.93 | -24.38 | -27.29 | -28.89 | -24.75 | -15.04 | -7.83 | -0.03 | -0.04 | -0.03 | -0.03 | -0.03 | -0.03 | -0.04 | -0.04 | -0.04 | 13.39 | 4.60 | -6.34 | -15.85 | -45.63 | -52.82 | -57.19 | -73.66 | -72.21 | -72.80 | -77.39 | -75.47 | -16.57 | -19.92 | -24.07 |
ROA % |
-14.70 | -10.85 | -10.68 | -9.34 | -14.00 | -17.60 | -18.38 | -13.64 | -17.55 | -16.80 | -16.41 | -8.67 | -13.59 | -14.59 | -15.92 | -14.41 | -17.41 | -15.51 | -14.50 | -13.83 | -14.10 | -19.88 | -19.05 | -19.00 | -22.42 | -22.29 | -24.64 | -25.71 | -22.02 | -13.38 | -6.97 | -0.03 | -0.03 | -0.03 | -0.03 | -0.02 | -0.02 | -0.03 | -0.03 | -0.03 | 11.53 | 3.96 | -5.46 | -13.64 | -37.63 | -42.21 | -44.44 | -56.01 | -54.95 | -55.44 | -58.99 | -57.60 | -12.65 | -15.20 | -18.37 |
ROCE % |
-18.33 | -14.10 | -13.85 | -11.21 | -16.54 | -20.10 | -20.38 | -14.91 | -19.08 | -17.91 | -17.40 | -9.21 | -14.44 | -15.51 | -17.00 | -15.65 | -19.19 | -17.49 | -16.75 | -15.76 | -25.38 | -31.46 | -30.53 | -20.65 | -30.46 | -30.66 | -33.27 | -24.90 | -33.13 | -31.56 | -33.58 | -27.34 | -32.21 | -28.84 | -26.51 | -18.58 | -29.24 | -35.03 | -37.75 | -31.08 | -39.90 | -38.06 | -39.34 | -29.29 | -45.17 | -52.23 | -56.64 | -57.29 | -73.92 | -74.67 | -75.13 | -53.65 | -16.63 | -15.84 | -21.18 |
Current Ratio |
19.0 | 20.1 | 20.5 | 17.0 | 19.6 | 19.4 | 20.9 | 18.9 | 14.8 | 17.6 | 22.1 | 23.4 | 17.8 | 21.1 | 25.8 | 18.4 | 18.4 | 18.4 | 18.4 | 18.4 | 18.4 | 18.4 | 18.4 | 18.8 | 18.8 | 18.8 | 18.8 | 9.1 | 9.1 | 9.1 | 9.1 | 7.5 | 7.5 | 7.5 | 7.5 | 7.4 | 7.4 | 7.4 | 7.4 | 5.2 | 5.2 | 5.2 | 5.2 | 7.2 | 7.2 | 7.2 | 7.2 | 4.2 | 4.2 | 4.2 | 4.2 | 4.2 | 4.2 | 4.2 | 4.2 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | 45.6 | 45.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 91.4 | 168339.1 | 168339.1 | 84169.6 | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | 45.6 | 45.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 91.4 | 168339.1 | 168339.1 | 84169.6 | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | 45.6 | 45.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 91.4 | 168339.1 | 168339.1 | 84169.6 | - | - | - | - | - | - | - | - |
All numbers in USD currency